StockVS

Colgate-Palmolive Company (CL) Stock Analysis

Consumer Defensive

Colgate-Palmolive Company

$89.85

$-0.76 (-0.84%)

Last Updated: May 26, 2026

Price History

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Company Overview

The Colgate-Palmolive Company manufactures and sells consumer products across the United States and international markets through two primary segments: Oral, Personal and Home Care, and Pet Nutrition. This enterprise operates within the Consumer Defensive sector, specifically the Household & Personal Products industry, positioning it as a provider of essential daily necessities that maintain relatively stable demand regardless of broader economic fluctuations. The company demonstrates significant scale with a market capitalization of $67.63B, annual revenue of $20.38B, and an employee base of 33,600. These figures indicate a massive global footprint where the $67.63B market cap reflects the market's valuation of its durable competitive advantages, while the $20.38B in annual revenue underscores the substantial volume of goods required to sustain household hygiene routines worldwide.

Financial Health

The company reports a Trailing Twelve Month revenue of $20.38B with a Net Income of $2.13B and EBITDA of $4.87B. The substantial gap between the $20.38B revenue and the $2.13B net income reveals a cost structure where approximately 90% of top-line sales are consumed by cost of goods sold and operating expenses before reaching the bottom line. Free cash flow stands at $3.08B, which provides the company with significant financial flexibility to fund capital expenditures, manage working capital requirements, or pursue strategic acquisitions without relying solely on external financing. Profitability is analyzed through three distinct margins: a Gross Margin of 60.1% indicates strong pricing power and efficient production scaling; an Operating Margin of 20.4% demonstrates effective control over administrative and distribution costs; and a Profit Margin of 10.5% confirms the ability to convert revenue into net earnings. The balance sheet shows a Cash position of $1.40B against Total Debt of $8.55B, resulting in a Debt to Equity ratio of 2343.56, which suggests a highly leveraged capital structure relative to shareholders' equity. Liquidity is assessed via a Current Ratio of 0.83, indicating that current assets are insufficient to cover current liabilities on a strict basis, suggesting a reliance on operational cash flow to meet short-term obligations. Return on Equity is reported at 497.5% while Return on Assets is 16.4%, metrics that reveal high leverage amplifying returns to shareholders but also exposing the asset base to significant debt-related risks.

Valuation Assessment

Valuation multiples include a P/E Ratio (TTM) of 32.05 and a Forward P/E of 20.34. The difference between these figures implies that the market expects earnings growth that would reduce the valuation multiple over time, as the forward multiple is significantly lower than the trailing multiple. The Price to Book ratio is listed at 1258.06, a figure that indicates a massive market premium over the company's book value, typical for firms with substantial retained earnings and intangible assets not fully captured on the balance sheet. Alternative valuation metrics show a Price to Sales ratio of 3.32 and an EV/EBITDA of 15.41, suggesting the company is valued at a premium relative to its sales and earnings before interest, taxes, depreciation, and amortization. Price metrics define a trading range between a 52-Week High of $99.33 and a 52-Week Low of $74.55; without the current price explicitly provided in the facts, the relative position cannot be calculated as a percentage, though the range establishes the historical volatility band. The Beta is 0.26, indicating that the stock price exhibits significantly lower volatility relative to the broader market, moving less than one-third as much as the market index in typical market conditions.

Growth & Income

Revenue growth is recorded at 5.8% year-over-year, while Earnings Growth is listed as N/A. The absence of a specific earnings growth percentage prevents a direct comparison of whether earnings are growing faster or slower than revenue, though the 5.8% revenue expansion indicates a steady top-line trajectory. As a dividend payer, the company offers a Dividend Yield of 2.5% with a Payout Ratio of 78.3%. A payout ratio of 78.3% implies that the vast majority of net income is distributed to shareholders, which must be monitored for sustainability given the high leverage and the need to maintain cash flow for debt servicing. Since earnings growth data is not explicitly quantified, the sustainability of the dividend depends on maintaining the current profit margin levels and cash flow generation capabilities. The overall growth and income profile presents a mix of steady revenue expansion and a high-yield dividend, though the high payout ratio and leveraged balance sheet require careful monitoring of future cash flows to ensure the ability to sustain both debt obligations and shareholder returns.

Peer Comparison

Colgate-Palmolive Company (CL) operates in the Household & Personal Products industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Colgate-Palmolive Company CL $71.90B 34.8
The Procter & Gamble Company PG $336.34B 21.1
Unilever PLC UL $123.97B 19.0
Kenvue Inc. KVUE $33.58B 20.8

The Household & Personal Products industry average P/E ratio is 29.9x. Colgate-Palmolive Company trades at a P/E of 34.8.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Colgate-Palmolive Company

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill's Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Visit website →

Key Statistics

Market Cap
$71.90B
P/E Ratio
34.83
52-Week High
$99.33
52-Week Low
$74.55
Avg Volume
5.90M
Beta
0.30
Dividend Yield
2.36%

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
33,600